On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

China Health Resource, Inc. (CHRI.OB) – All the Right Ingredients

If one was to ask the average man in the street where he thought he’d get the best investment returns, almost invariably he’d say “China” and for good reason. For the past 12 years, China’s been growing at a rate above 6%, and in the past 4 years alone , it’s been closer to 12%.Compared to the rather dismal growth rate the US economy has been experiencing, it makes a lot of sense to consider the Chinese alternative.

But history is full of good intentioned ideas that shipwrecked on the way to glory. China is certainly no different. Just because a company is based in China, or has a China based market, or creates and produces in China, it doesn’t necessarily mean that company is going to be a success. History unfortunately, is full of Chinese companies that met the same rocky reef and sank. So then, what makes the difference between a company that makes US Analysts warm and fuzzy, yet crashes on the rocks, versus the Chinese company that succeeds and grows? It’s the culture acceptance.

China is a country wrapped in thousands of years of culture, and what plays well in the US or Europe, may not necessarily play so well there. Attitudes and culture form the basis for homegrown demand in China. So it goes without saying, that the single best idea one could possibly launch is a company that appeals to the wants and desires of Chinese culture, but also finds a niche on the global stage. Satisfy these two situations, and you’ve dialed in the basic ingredients for a very successful company.

China Health Resource Inc has done just that, and could very well be a tremendous investing opportunity. First, let’s discuss who they are, and what they bring to the table. Through its subsidiary, Suining Yinfa DAR Industrial Co., Ltd, China Health Resource, Inc. (CHRI) is committed to developing traditional Chinese herbal medicine and produces, processes and sells one of the major Chinese herbs, Dahurian Angelica Root. This herb is widely used by many to alleviate pain, high blood pressure, cancer and many other illnesses.

At first blush one might think that this is nothing to get very excited about, I mean we’re talking about some “herbal medicine”. But you’d be sadly mistaken. Herbal medicine has been part of the Chinese culture for thousands of years and the standard Chinese apothecary is brimming with traditional herbal cures. So ingrained in the history of China is the natural approach to healing, that its modern medicines that have to fight for “shelf space”.

So, if we look at CHRI as a well accepted Chinese company, we are already in the driver seat. But, what about the rest of the world? This is where CHRI is going to deliver the “two” in the classic “one/two” punch. A movement has been going on for some 30 plus years in the developed countries to explore the more natural homeopathic and herbal approach to curing illness, and the statistics are quite stunning. In the US, where the FDA, and AMA blanket the airwaves with the most modern of medical drug allure, herbal medicine is growing at a brisk 20%+ per annum, and in Europe, where a more natural approach to such things is, well, more natural to them, the growth rate exceeds 30%. Combined, the total dollars spent on herbal related medicines is north of 25 billion dollars per year, and growing at those incredible rates we mentioned.

It’s always been my approach that when dissecting a business to determine if it warrants a closer look, one of the most basic necessities is that there is demand and growth. The natural medicine segment of the healthcare market certainly delivers on that, and with China Health Resource we reap the benefits of the acceptance of the Chinese marketplace. This is paramount, and what will indeed separate the winners from the wannabee’s. When you look at the one billion plus possible consumers in China, the single most important question you can ask is, “will the Chinese buy it”. With herbal medicine, the answer’s already been carved in historical stone. Yes indeed they will.

There is a litany of topics that make China Health an interesting company, and we’ve only discussed one of them here. We’ve settled the “is there any demand” question quite remarkably. We haven’t even touched on their bellwether product called DAR or Dahurian Angelica Root. It is widely accepted that when boiled, and applied in various forms DAR has been shown to cure the common cold, headache, toothache and stomach-ache and is used also used in pain, high blood pressure, and even cancer treatments. We also haven’t touched on the recent blockbuster news that they have received what one could consider the equivalent to a Chinese FDA approval for manufacture and distribution of this popular medicine.

China Health Resource has a lot potential, and we’ve only addressed one avenue of it here. It’s our opinion that you should pull up a chair and take a few minutes to get acquainted with CHRI, it might be one of the best friendships you make in your investing career.

Let us hear your thoughts: China Health Resource, Inc. Message Board

Archives

Select A Month
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • July 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • January 2014
  • December 2013
  • November 2013
  • October 2013
  • September 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012
  • July 2012
  • June 2012
  • May 2012
  • April 2012
  • March 2012
  • February 2012
  • January 2012
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011
  • January 2011
  • December 2010
  • November 2010
  • October 2010
  • September 2010
  • August 2010
  • July 2010
  • June 2010
  • May 2010
  • April 2010
  • March 2010
  • February 2010
  • January 2010
  • December 2009
  • November 2009
  • October 2009
  • September 2009
  • August 2009
  • July 2009
  • June 2009
  • May 2009
  • April 2009
  • March 2009
  • February 2009
  • January 2009
  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • September 2007
  • August 2007
  • July 2007
  • June 2007
  • May 2007
  • April 2007
  • March 2007
  • February 2007
  • January 2007
  • December 2006
  • November 2006
  • October 2006
  • September 2006
  • August 2006
  • July 2006
  • June 2006
  • May 2006
  • April 2006
  • March 2006
  • January 2006
  • December 2005
  • October 2005
  • September 2005
  • Market Basics

    New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

    The Basics

    Newsletter Publishers

    Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

    Register

    Public Companies

    Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

    Get Covered